AI Risks · Fierce Biotech

Takeda drops AstraZeneca-partnered neurological program after phase 2 failure

AI and Machine Learning · CRO · Special Reports; Trending. Biologics · Clinical Development · Ophthalmology · Cell & Gene Therapy · Fierce 50.

Read the original at Fierce Biotech ↗

Topics
Healthcare
Tracked via
“AI Falures”